Preliminary clinical trials with oxamniquine, a new antischistosomal agent.
D000871:Anthelmintics / Q000627:therapeutic use*; D002214:Capsules; D002986:Clinical Trials as Topic; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D008297:Male; D009574:Nitro Compounds / Q000008:administration & dosage / Q000627:therapeutic use; D010270:Parasite Egg Count; D011437:Propylamines / Q000008:administration & dosage / Q000627:therapeutic use; D011804:Quinolines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D012550:Schistosoma mansoni; D012552:Schistosomiasis / Q000188:drug therapy*; D012556:Schistosomicides / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use
D000871:Anthelmintics; D002214:Capsules; D009574:Nitro Compounds; D011437:Propylamines; D011804:Quinolines; D012556:Schistosomicides